1.Magnetic Resonance Imaging and Sonographic Features before and after Surgery in Carpal Tunnel Syndrome: Association with Clinical Findings
Mahla DALIRI ; Motahareh EBRAHIMNEJAD ; Samane NAJAFI ; Behzad AMINZADEH ; Maryam EMADZADEH ; Ehsan MORADI ; Ali MORADI
Clinics in Orthopedic Surgery 2022;14(4):603-612
Background:
The interest in ultrasonography (US) and magnetic resonance imaging (MRI) assessment of the patients with carpal tunnel syndrome (CTS) is growing. This paper aimed to find the correlation of postoperative changes in these modalities’ parameters with clinical outcomes.
Methods:
Boston CTS questionnaire-symptom severity (BQ-SS), Boston CTS questionnaire-functional status (BQ-FS), and visual analog scale (VAS) questionnaires (for pain, paresthesia, and grip weakness assessment) were used to evaluate clinical outcomes. Various imaging parameters of the median nerve and carpal tunnel were evaluated using US and MRI at two levels of the hook of the hamate (distal) and the pisiform (proximal) once preoperatively and then 3 months postoperatively. Corresponding US and MRI parameter measures were compared, and correlational analysis was performed between alteration of imaging findings and changes in clinical parameters postoperatively.
Results:
Patients’ functional status (BQ-FS score) was positively correlated with the nerve width both in US and MRI at the proximal level (r = 0.457 and r = 0.453, respectively) and also with the MRI nerve circumference at the distal level (r = –0.482). Correlation between paresthesia and the nerve width was notable in MRI at the distal hook of the hamate level (r = –0.403). Grip weakness VAS score was correlated with the nerve width-to-height ratio (WHR) in US at the distal level (r = 0.432).
Conclusions
Changes in US and MRI parameters of the median nerve width, circumference, and WHR were associated with clinical changes in patients with CTS after surgery.
2.Medication errors among nurses in teaching hospitals in the west of Iran: what we need to know about prevalence, types, and barriers to reporting.
Afshin FATHI ; Mohammad HAJIZADEH ; Khalil MORADI ; Hamed ZANDIAN ; Maryam DEZHKAMEH ; Shima KAZEMZADEH ; Satar REZAEI
Epidemiology and Health 2017;39(1):e2017022-
OBJECTIVES: This study aimed to examine the prevalence and types of medication errors (MEs), as well as barriers to reporting MEs, among nurses working in 7 teaching hospitals affiliated with Kermanshah University of Medical Sciences in 2016. METHODS: A convenience sampling method was used to select the study participants (n=500 nurses). A self-constructed questionnaire was employed to collect information on participants’ socio-demographic characteristics (10 items), their perceptions about the main causes of MEs (31 items), and barriers to reporting MEs to nurse managers (11 items). Data were collected from September 1 to November 30, 2016. Negative binomial regression was used to identify the main predictors of the frequency of MEs among nurses. RESULTS: The prevalence of MEs was 17.0% (95% confidence interval, 13.7 to 20.3%). The most common types of MEs were administering medications at the wrong time (24.0%), dosage errors (16.8%), and administering medications to the wrong patient (13.8%). A heavy workload and the type of shift work were considered to be the main causes of MEs by nursing staff. Our findings showed that 45.0% of nurses did not report MEs. A heavy workload due to a high number of patients was the most important reason for not reporting MEs (mean score, 3.57±1.03) among nurses. Being male, having a second unrelated job, and fixed shift work significantly increased MEs among nurses (p=0.001). CONCLUSIONS: Our study documented a high prevalence of MEs among nurses in the west of Iran. A heavy workload was considered to be the most important barrier to reporting MEs among nurses. Thus, appropriate strategies (e.g., reducing the nursing staff workload) should be developed to address MEs and improve patient safety in hospital settings in Iran.
Hospitals, Teaching*
;
Humans
;
Iran*
;
Male
;
Medication Errors*
;
Methods
;
Nurse Administrators
;
Nursing Staff
;
Patient Safety
;
Prevalence*
3.Medication errors among nurses in teaching hospitals in the west of Iran: what we need to know about prevalence, types, and barriers to reporting
Afshin FATHI ; Mohammad HAJIZADEH ; Khalil MORADI ; Hamed ZANDIAN ; Maryam DEZHKAMEH ; Shima KAZEMZADEH ; Satar REZAEI
Epidemiology and Health 2017;39(1):2017022-
OBJECTIVES: This study aimed to examine the prevalence and types of medication errors (MEs), as well as barriers to reporting MEs, among nurses working in 7 teaching hospitals affiliated with Kermanshah University of Medical Sciences in 2016.METHODS: A convenience sampling method was used to select the study participants (n=500 nurses). A self-constructed questionnaire was employed to collect information on participants’ socio-demographic characteristics (10 items), their perceptions about the main causes of MEs (31 items), and barriers to reporting MEs to nurse managers (11 items). Data were collected from September 1 to November 30, 2016. Negative binomial regression was used to identify the main predictors of the frequency of MEs among nurses.RESULTS: The prevalence of MEs was 17.0% (95% confidence interval, 13.7 to 20.3%). The most common types of MEs were administering medications at the wrong time (24.0%), dosage errors (16.8%), and administering medications to the wrong patient (13.8%). A heavy workload and the type of shift work were considered to be the main causes of MEs by nursing staff. Our findings showed that 45.0% of nurses did not report MEs. A heavy workload due to a high number of patients was the most important reason for not reporting MEs (mean score, 3.57±1.03) among nurses. Being male, having a second unrelated job, and fixed shift work significantly increased MEs among nurses (p=0.001).CONCLUSIONS: Our study documented a high prevalence of MEs among nurses in the west of Iran. A heavy workload was considered to be the most important barrier to reporting MEs among nurses. Thus, appropriate strategies (e.g., reducing the nursing staff workload) should be developed to address MEs and improve patient safety in hospital settings in Iran.
Hospitals, Teaching
;
Humans
;
Iran
;
Male
;
Medication Errors
;
Methods
;
Nurse Administrators
;
Nursing Staff
;
Patient Safety
;
Prevalence
4.Erratum to: Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.
Mohammad Hassan HEIDARI ; Abolfazl MOVAFAGH ; Mohammad Amin ABDOLLAHIFAR ; Shabnam ABDI ; Mohamadreza Mashhoudi BAREZ ; Hadi AZIMI ; Afshin MORADI ; Amin BAGHERI ; Matineh HEIDARI ; Jafar HESSAM MOHSENI ; Maryam TADAYON ; Hoda MIRSAFIAN ; Mahdi GHATREHSAMANI
Anatomy & Cell Biology 2017;50(2):162-162
No abstract available.
5.Nutritional Care in Iranian Intensive Care Units.
Maryam SHABANPUR ; Seyed Mostafa NACHVAK ; Shima MORADI ; Safora HEDAYATI ; Mahboobe HOSSEINIKIA ; Yahya PASDAR ; Shahrbanoo GHOLIZADEH ; Mehnoosh SAMADI
Clinical Nutrition Research 2018;7(2):136-145
Intensive care units (ICUs) provides intensive treatment medicine to avoid complications such as malnutrition, infection and even death. As very little is currently known about the nutritional practices in Iranian ICUs, this study attempted to assess the various aspects of current nutrition support practices in Iranian ICUs. We conducted a cross-sectional study on 150 critically ill patients at 18 ICUs in 12 hospitals located in 2 provinces of Iran from February 2015 to March 2016. Data were collected through interview with supervisors of ICUs, medical record reviews and direct observation of patients during feeding. Our study showed that hospital-prepared enteral tube feeding formulas are the main formulas used in Iranian hospitals. None of the dietitians worked exclusively an ICU and only 30% of patients received diet counselling. Regular monitoring of nutritional status, daily energy and protein intake were not recorded in any of the participating ICUs. Patients were not monitored for anthropometric measurements such as mid-arm circumference (MAC) and electrolyte status. The nasogastric tube was not switched to percutaneous endoscopic gastrostomy or jejunostomy (PEG/PEGJ) in approximately 85% of patients receiving long-term enteral nutrition (EN) support. Our findings demonstrated that the quality of nutritional care was inappropriate in Iranian ICUs and improvement of nutritional care services within Iranian ICUs is necessary.
Critical Care*
;
Critical Illness
;
Cross-Sectional Studies
;
Diet
;
Enteral Nutrition
;
Gastrostomy
;
Humans
;
Intensive Care Units*
;
Iran
;
Jejunostomy
;
Malnutrition
;
Medical Records
;
Nutritional Status
;
Nutritionists
6.Analysis of survival data in thalassemia patients in Shiraz, Iran.
Abdolreza RAJAEEFARD ; Mahmoud HAJIPOUR ; Hamid Reza TABATABAEE ; Jafar HASSANZADEH ; Shahab REZAEIAN ; Zahra MORADI ; Mehdi SHARAFI ; Mohsen SHAFIEE ; Ali SEMATI ; Sanaz SAFAEI ; Maryam SOLTANI
Epidemiology and Health 2015;37(1):e2015031-
OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality from thalassemia. METHODS: This retrospective cohort study was conducted based on a retrospective review of the medical records of 911 beta-thalassemia patients in 2014. Data analysis was conducted using the Kaplan-Meier method and Cox regression analysis. RESULTS: Overall, 212 patients (23.3%) died, and 26.8% had thalassemia intermedia. The 20-year, 40-year, and 60-year survival rates were 85%, 63%, and 54%, respectively. Both crude and adjusted analyses found that education, marital status, ferritin levels, and comorbidities were related to mortality. CONCLUSIONS: Sociodemographic and hematological factors were found to be significantly associated with the survival rate of thalassemia. Addressing these factors may help healthcare providers and physicians to provide the best possible care and to improve the survival rate.
beta-Thalassemia
;
Cohort Studies
;
Comorbidity
;
Education
;
Ferritins
;
Health Personnel
;
Humans
;
Iran*
;
Kaplan-Meier Estimate
;
Marital Status
;
Medical Records
;
Mortality
;
Retrospective Studies
;
Statistics as Topic
;
Survival Rate
;
Thalassemia*
7.The protective effect of zinc oxide and selenium oxide nanoparticles on the functional parameters of rat sperm during vitrification
Nafiseh Tavakolpoor SALEH ; Zohreh HOSSEINZADEH ; Narges Gholami BANADKUKI ; Maryam Salehi NOVIN ; Sanaz Saljooghi ZAMAN ; Tohid Moradi GARDESHI
Clinical and Experimental Reproductive Medicine 2024;51(1):20-27
Objective:
While sperm freezing (cryopreservation) is an effective method for preserving fertility, it can potentially harm the structure and function of sperm due to an increase in the production of reactive oxygen species. This study aimed to assess the impact of zinc oxide nanoparticles (ZnONPs) and selenium oxide nanoparticles (SeONPs) on various sperm functional parameters, including motility, plasma membrane integrity (PMI), mitochondrial membrane potential (MMP), acrosome membrane integrity (ACi), and malondialdehyde (MDA) levels.
Methods:
Semen samples were collected from 20 Albino Wistar rats. These samples were then divided into six groups: fresh, cryopreservation control, and groups supplemented with SeONPs (1, 2, 5 μg/mL) and ZnONPs (0.1, 1, 10 μg/mL).
Results:
Statistical analysis revealed that all concentrations of SeONPs increased total motility and progressive reduction of MDA levels compared to the cryopreservation control group (p<0.05). However, supplementation with ZnONPs did not affect these parameters (p>0.05). Conversely, supplements of 1 and 2 μg/mL SeONPs and 1 μg/mL ZnONPs contributed to the improvement of PMI and ACi (p<0.05). Yet, no significant change was observed in MMP with any concentration of SeONPs and ZnONPs compared to the cryopreservation control group (p>0.05).
Conclusion
The findings suggest that optimal concentrations of SeONPs may enhance sperm parameters during the freezing process.
8.Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.
Mohammad Hassan HEIDARI ; Abolfazl MOVAFAGH ; Mohammad Amin ABDOLLAHIFAR ; Shabnam ABDI ; Mohamadreza Mashhoudi BAREZ ; Hadi AZIMI ; Afshin MORADI ; Amin BAGHERI ; Matineh HEIDARI ; Jafar HESSAM MOHSENI ; Maryam TADAYON ; Hoda MIRSAFIAN ; Mahdi GHATREHSAMANI
Anatomy & Cell Biology 2017;50(1):69-72
Prostate cancer is the most common cancer type in men and is the second cause of death, due to cancer, in patients over 50, after lung cancer. Prostate specific antigen (PSA) is a widely used tumor marker for prostate cancer. Recently, PSA is discovered in non-prostatic cancer tissues in men and women raising doubts about its specificity for prostatic tissues. PSA exists in low serum level in healthy men and in higher levels in many prostate disorders, including prostatitis and prostate cancer. Thus, a supplementary tumor marker is needed to accurately diagnose the cancer and to observe the patient after treatment. Recently, soluble human leukocyte antigen-G (sHLA-G) has been introduced as a new tumor marker for different cancer types, including colorectal, breast, lung, and ovary. The present descriptive-experimental study was carried out including patients with malignant prostate tumor, patients with benign prostate tumor, and a group of health men as the control group, as judged by an oncologist as well as a pathologist. After sterile blood sampling, sHLA-G was measured by enzyme-linked immunosorbent assay in each group. The data was then analyzed using one-way ANOVA. P≤0.05 was considered as statistically significant. The results showed that the mean of sHLA-G level was high in patients. Also, it was found that there was a significant difference in sHLA serum level between the three groups. The data revealed that sHLA-G can be a novel supplementary tumor marker in addition to PSA to diagnose prostate cancer.
Breast
;
Cause of Death
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Humans
;
Leukocytes
;
Lung
;
Lung Neoplasms
;
Male
;
Ovary
;
Prostate*
;
Prostate-Specific Antigen
;
Prostatic Neoplasms*
;
Prostatitis
;
Sensitivity and Specificity
9. Prevalence of West Nile virus in Mashhad, Iran: A population-based study
Zahra MESHKAT ; Sadegh CHINIKAR ; Maryam MORADI ; Tahmineh JALALI ; Sahar KHAKIFIROUZ ; Nariman SHAHHOSSEINI ; MohammadTaghi SHAKERI ; Lida MANAVIFAR ; Hessam MIRSHAHABI
Asian Pacific Journal of Tropical Medicine 2015;8(3):203-205
Objective: To evaluate the prevalence of West Nile virus seropositivity in the general population of Mashhad, Northeast of Iran. Methods: One hundred and eighty two individuals living in the city of Mashhad were studied using cluster sampling method. Both IgM and IgG antibodies against WNV were detected by ELISA method. Results: In this study, the overall IgG seroprevalence of positive West Nile virus was 11%; however, IgM antibody was not found in the participants. Conclusions: Our study suggested that the prevalence rate of West virus is considerable in Mashhad city. It seems necessary for clinicians and health care workers to be aware of WNV infection in the Northeast Iran.